Evaluation of Role of Inflammatory Markers for the Prediction of Recurrence on Pathologic T1a Clear Cell Renal Cell Cancer Patients
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 1
Abstract
Objective: To evaluate the role of neutrophil to lymphocyte ratio (NLR), high sensitive C-reactive protein (hs-CRP) and procalcitonin levels in the prediction of tumor recurrence in stage T1aN0M0 clear cell renal cell carcinoma (RCC). Materials and Methods: We assessed 400 patients pathologically staged as T1aN0M0 clear cell RCC after radical or partial nephrectomy, in two institutions, between January 2007 and March 2014. Data of demographics, neutrophil and lymphocyte counts, NLR, hs-CRP, procalcitonin levels, tumor size, Fuhrmann nuclear grade and disease recurrence were collected. The primary outcome measure of this study was the evaluation of the relationship between NLR, hs-CRP and procalcitonin levels with recurrence free survival. Results: The mean age and the mean tumor size of the patients were 56.8±13.1 years and 29.3±7.7 mm, respectively. Mean NLR, hs-CRP and procalcitonin levels were 3.2±2.6, 0.822±0.404 mg/L and 0.088±0.05 ng/mL, respectively. Fuhrmann Grade 1-2 and Fuhrmann Grade 3-4 tumor were observed in 76% and 24% of total patients, respectively. The mean follow up of the patient was 32.8 months. Totally tumor recurrence was detected in 5 patients. The receiver-operating characteristic analysis revealed cut off values of 4.50 for the NLR, 0.655 mg/L for hs-CRP and 0.078 ng/mL for and procalcitonin levels. In the multivariate analysis, the Fuhrmann grade 3-4 (p=0.017) and NLR values ≥4.50 (p=0.025) were detected to be associated with increased risk of recurrence. Conclusions: High preoperative NLR value may be associated with increased risk of recurrence in stage pathologic T1a RCC patients. Studies with longer duration of follow up, prospective and larger populations are needed.
Authors and Affiliations
Mehmet İlker Gökçe, Nurullah Hamidi, Barış Esen, Semih Tangal, Evren Süer, Sümer Baltacı
Keywords
Related Articles
- EP ID EP228266
- DOI 10.4274/uob.517
- Views 88
- Downloads 0
Metastasis Targeted Therapies in Renal Cell Cancer
Metastatic renal cell cancer is a malignant disease and its treatment has been not been described clearly yet. These patients are generally symptomatic and resistant to current treatment modalities. Radiotherapy, chemoth...
A Rare Presentation of Germ Cell Neoplasia: Persistant Müllerian Duct Syndrome
Persistent Müllerian duct syndrome is a rare form of pseudohermaphroditism. This article is made of two case reports showing malignant transformation. The first case was a 36-year-old male who presented with infertility....
Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature
The most common primary bladder cancer are transitional cell (urothelial) carcinomas. However, there are several uncommon but significant bladder lesions that must be differentiated from urothelial carcinomas. These blad...
Prostate-specific Membrane Antigen-Based Nanomedicine Applications in the Diagnosis and Treatment of Prostate Cancer
Nanomedicine is a branch of nanotechnology that includes the development of nanostructures and nanoanalytical systems for various medical applications. The rapid development of nanomedicine offers new possibilities in ca...
Evaluation of the Relationship between Pathology Results and Pain Scores in Patients Who Underwent Transrectal Ultrasound-Guided Prostate
Objectives: In this study, we assessed the relationship between pain scores and the pathology results of patients who underwent transrectal ultrasound-guided prostate biopsy (TRUS-PBx). Materials and Methods: A total of...